Client: Emerging biotechnology company
Project: Find best licensing deal
for phase III product
Assessed valuation of a phase III clinical program
in Parkinson's disease
- Defined market value (rNPV projections, benchmarking)
- Examined future clinical development & financial consequences
- Performed competitive analysis
Developed partnering strategy
- Assessed strengths and weaknesses and clarified
positioning of product
- Ranked potential partnering candidates
- Generated non-confidential & confidential materials
- Initiated/reactivated and aligned partner contacts despite history of negative
responses
- Prepared and coordinated due diligence processes
Implemented the strategy leading to a transaction
- Initiated and managed partnering meetings
- Developed optimal deal structures
Facilitated deal closing
- Orchestrated competitive forces by negotiating with 3 companies in parallel
- Closed deal successfully with mid-size pharma
company
|
|
